Cargando…
The Role of Complement in HSCT-TMA: Basic Science to Clinical Practice
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) is a common complication occurring post-HSCT and is associated with substantial morbidity and mortality if not promptly identified and treated. Emerging evidence suggests a central role for the complement system...
Autores principales: | Meri, Seppo, Bunjes, Donald, Cofiell, Roxanne, Jodele, Sonata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402756/ https://www.ncbi.nlm.nih.gov/pubmed/35781192 http://dx.doi.org/10.1007/s12325-022-02184-4 |
Ejemplares similares
-
Tackling COVID‐19 infection through complement‐targeted immunotherapy
por: Jodele, Sonata, et al.
Publicado: (2020) -
Peering into the darkness of drug-induced thrombotic microangiopathy: complement, are you in there?
por: Sabulski, Anthony, et al.
Publicado: (2023) -
Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT
por: Mizuno, Kana, et al.
Publicado: (2022) -
Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy
por: Gavriilaki, Eleni, et al.
Publicado: (2021) -
Complement in malaria: immune evasion strategies and role in protective immunity
por: Kiyuka, Patience Kerubo, et al.
Publicado: (2020)